Serum level of APRIL/BLyS in Behçet's disease patients: Clinical significance in uveitis and disease activity

Modern Rheumatology

Volumn 23, Issue 3, 2013, Pages 542-546

  Gheita, Tamer A ^a   Raafat, Hala ^a   Khalil, Hossam ^b   Hussein, Hani ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b BENI SUEF UNIVERSITY   (Egypt)

Author keywords

APRIL; Beh et's disease; BLyS; Uveitis

Indexed keywords

ADALIMUMAB; APRIL PROTEIN; INFLIXIMAB; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORNEA ULCER; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; IRIDOCYCLITIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; REMISSION; UVEITIS;

ADULT; B-CELL ACTIVATING FACTOR; BEHCET SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; UVEITIS;

EID: 84877772623     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0694-x     Document Type: Article

References (21)

1. Sadreddini S, Noshad H, Molaeefard M, Noshad R. Treatment of retinal vasculitis in Behçet's disease with rituximab. Mod Rheumatol. 2008;18(3):306-8.
2. Davatchi F, Shams H, Rezaipoor M, Sadeghi-Abdollahi B, Shahram F, Nadji A, et al. Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study). Int J Rheum Dis. 2010;13(3):246-52.
3. Yazici H. The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol. 1997;14(1):1-10.
4. Charteris DG, Barton K, McCartney AC, Lightman SL. CD4+ lymphocyte involvement in ocular Behçet's disease. Autoimmunity. 1992;12(3):201-6.
5. Treusch M, Vonthein R, Baur M, Günaydin I, Koch S, Stübiger N, et al. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Rheumatology (Oxford). 2004;43(10):1275-82.
6. Suh CH, Park YB, Song J, Lee CH, Lee SK. Oligoclonal B lymphocyte expansion in the synovium of a patient with Behçet's disease. Arthritis Rheum. 2001;44(7):1707-12.
7. Ekşioglu-Demiralp E, Kibaroglu A, Direskeneli H, Yavuz S, Karsli F, Yurdakul S, et al. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets. J Rheumatol. 1999;26(4):826-32.
8. Le Pottier L, Bendaoud B, Renaudineau Y, Youinou P, Pers JO, Daridon C. New ELISA for B cell-activating factor. Clin Chem. 2009;55(10):1843-51.
9. Krivosikova M, Dallos T, Maslinski W, Buc M. B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases. Bratisl Lek Listy. 2009;110(3):137-45.
10. Hamzaoui K, Houman H, Ben Dhifallah I, Kamoun M, Hamzaoui A. Serum BAFF levels and skin mRNA expression in patients with Behçet's disease. Clin Exp Rheumatol. 2008;26[4 Suppl 50]:S64-71.
11. Gheita TA, Bassyouni IH, Emad Y, El-Din AM, Abdel-Rasheed E, Hussein H. Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: relation to clinical manifestations and disease activity. Jt Bone Spine. 2012;79(3):285-90.
12. Hirohata S. Histopathology of central nervous system lesions in Behçet's disease. J Neurol Sci. 2008;267(1-2):41-7.
13. Hamzaoui K, Houman H, Hentati F, Hamzaoui A. BAFF is up-regulated in central nervous system of neuro-Behçet's disease. J Neuroimmunol. 2008;200(1-2):111-4.
14. Hamzaoui A, Chelbi H, Sassi FH, Hamzaoui K. Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behçet's disease with pulmonary involvement. Oxid Med Cell Longev. 2010;3(2):122-8.
15. Suzuki N, Sakane T, Ueda Y, Tsunematsu T. Abnormal B cell function in patients with Behçet's disease. Arthritis Rheum. 1986;29(2):212-9.
16. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disaese. Lancet. 1990;335:1078-80.
17. Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behçet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford). 1999;38(8):728-33.
18. Zamir E, Bodaghi B, Tugal-Tutkun I, See RF, Charlotte F, Wang RC, et al. Conjunctival ulcers in Behçet's disease. Ophthalmology. 2003;110(6):1137-41.
19. Belfort R Jr, Moura NC, Mendes NF. T and B lymphocytes in the aqueous humor of patients with uveitis. Arch Ophthalmol. 1982;100(3):465-7.
20. Fawzy SM, Gheita TA, El-Nabarawy E, El-Demellawy HH, Shaker OG. Serum BAFF level and its correlations with various disease parameters in patients with systemic sclerosis and systemic lupus erythematosus. Egypt Rheumatol. 2011;33(1):45-51.
21. Kiyama K, Kawabata D, Hosono Y, Kitagori K, Yukawa N, Yoshifuji H, et al. Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance. Arthritis Res Ther. 2012;14(2):R86.